KALYANAM SHIVKUMAR, MD
Osteopathic Medicine in Los Angeles, CA
License number
California A54053
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
200 Medical Plz #365C, Los Angeles, CA 90095
Phone
(310) 206-2235
(310) 825-2092 (Fax)
(310) 206-2265
(310) 794-6492 (Fax)
(310) 825-2092 (Fax)
(310) 206-2265
(310) 794-6492 (Fax)
Personal information
See more information about KALYANAM SHIVKUMAR at radaris.comName
Address
Phone
522 Cashmere Ter, Los Angeles, CA 90049
200 Ucla Medical Plz, West Los Angeles, CA 90095
522 Cashmere St, Los Angeles, CA 90049
Organization information
See more information about KALYANAM SHIVKUMAR at bizstanding.comKalyanam Shivkumar MD,MBBS,PHD
200 Ucla Medical Plz, Los Angeles, CA 90095
Industry:
Cardiologist, Interventional Cardiologist, Internist
Phone:
(310) 794-1707 (Phone)
Kalyanam Shivkumar
Ucla Medical Center - Kalyanam Shivkumar MD
100 Ucla Medical Plz STE 690, Los Angeles, CA 90095
Categories:
Cardiology Physicians & Surgeons
Phone:
(310) 206-2235 (Phone)
Professional information
Director, Ucla Cardiac Arrhythmia Center And Ep Programs At David Geffen School Of Medicine At Ucla
Position:
Professor of Medicine & Radiology, Director, UCLA Cardiac Arrhythmia Center and EP Programs at David Geffen School of Medicine at UCLA
Location:
Greater Los Angeles Area
Industry:
Hospital & Health Care
Work:
David Geffen School of Medicine at UCLA
since Jun 2002
-
Professor of Medicine & Radiology, Director, UCLA Cardiac Arrhythmia Center and EP Programs
University of Iowa
Jul 2000 - Jun 2002
-
Associate Director, Cardiac Electrophysiology
Education:
UCLA 1995 - 2000
Doctor of Philosophy (PhD) University of Madras 1985 - 1991
Doctor of Medicine (MD)
Doctor of Philosophy (PhD) University of Madras 1985 - 1991
Doctor of Medicine (MD)
Dr. Kalyanam Shivkumar - MD (Doctor of Medicine)
Hospitals:
Pacemaker Clinic
200 Ucla Medical Plz SUITE 330, Los Angeles 90095
Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles 90095
St. John Medical Center
1923 South Utica Ave, Tulsa 74104
Pacemaker Clinic
200 Ucla Medical Plz SUITE 330, Los Angeles 90095
Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles 90095
St. John Medical Center
1923 South Utica Ave, Tulsa 74104
200 Ucla Medical Plz SUITE 330, Los Angeles 90095
Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles 90095
St. John Medical Center
1923 South Utica Ave, Tulsa 74104
Pacemaker Clinic
200 Ucla Medical Plz SUITE 330, Los Angeles 90095
Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles 90095
St. John Medical Center
1923 South Utica Ave, Tulsa 74104
Philosophy:
Provide compassionate care utilizing the very best treatments that medical science can offer.
I belong to a group of physicians and allied health professionals who practice medicine, train future leaders of medicine and perform research to improve care.
Education:
Medical Schools
Madras Med College
Graduated: 1991
Madras Med College
Graduated: 1991
Defibrillation Shock Strength Determination Technology
US Patent:
2003019, Oct 16, 2003
Filed:
Jan 27, 2003
Appl. No.:
10/351143
Inventors:
Charles Swerdlow - Los Angeles CA, US
Kalyanam Shivkumar - Los Angeles CA, US
Kalyanam Shivkumar - Los Angeles CA, US
International Classification:
A61N001/39
US Classification:
607/008000
Abstract:
A method for determining a cardiac shock strength, for example the programmed first-therapeutic shock strength of an implantable cardioverter defibrillator (ICD), including the steps of sensing a change in a T-wave of an electrogram with respect to time such as the maximum of the first derivative of a T-wave of an electrogram; delivering a test shock by (i) delivering a test shock at a test-shock strength and at a test-shock time relating to the maximum of the first derivative of the T-wave with respect to time; and (ii) sensing for cardiac fibrillation. If fibrillation is not sensed, test-shock delivery is repeated at the same test-shock strength and at specific, different test-shock times relating to the maximum of the first derivative of the T-wave. If fibrillation is still not sensed, the shock strength is decreased and test shocks are repeated at the same specific test shock times relative to the maximum of the first derivative of the T-wave. And if fibrillation is sensed, the programmed therapeutic shock strength of the ICD is set as a function of the incrementally greater test-shock strength. Also disclosed is an apparatus for selecting a programmed first-shock strength of an ICD, including a shock subsystem for delivering therapeutic shocks and test shocks to the heart, and a ULV subsystem connected to the shock subsystem, to provide test shocks of test-shock strengths and at test-shock times relating to the maximum of the first derivative of the T-wave with respect to time, and to determine the therapeutic shock strength of the ICD as a function of the test-shock strengths.
Defibrillation Shock Strength Determination Technology
US Patent:
8401638, Mar 19, 2013
Filed:
Aug 21, 2007
Appl. No.:
11/894185
Inventors:
Charles D. Swerdlow - Los Angeles CA, US
Kalyanam Shivkumar - Los Angeles CA, US
Kalyanam Shivkumar - Los Angeles CA, US
Assignee:
Imperception, Inc. - Minneapolis MN
International Classification:
A61N 1/39
US Classification:
607 8
Abstract:
A method for determining a cardiac shock strength, for example the programmed first-therapeutic shock strength of an implantable cardioverter defibrillator (ICD), including the steps of sensing a change in a T-wave of an electrogram with respect to time such as the maximum of the first derivative of a T-wave of an electrogram; delivering a test shock by (i) delivering a test shock at a test-shock strength and at a test-shock time relating to the maximum of the first derivative of the T-wave with respect to time; and (ii) sensing for cardiac fibrillation. If fibrillation is not sensed, test-shock delivery is repeated at the same test-shock strength and at specific, different test-shock times relating to the maximum of the first derivative of the T-wave. If fibrillation is still not sensed, the shock strength is decreased and test shocks are repeated at the same specific test shock times relative to the maximum of the first derivative of the T-wave. And if fibrillation is sensed, the programmed therapeutic shock strength of the ICD is set as a function of the incrementally greater test-shock strength.
Methods And Systems For Gated Or Pulsed Application Of Ablative Energy In The Treatment Of Cardiac Disorders
US Patent:
7871408, Jan 18, 2011
Filed:
Oct 27, 2005
Appl. No.:
11/259881
Inventors:
Subramaniam Krishnan - Newport Beach CA, US
Kalyanam Shivkumar - Los Angeles CA, US
Suresh Rathnam - Hyderabad, IN
Kalyanam Shivkumar - Los Angeles CA, US
Suresh Rathnam - Hyderabad, IN
Assignee:
Henry Ford Health System - Detroit MI
International Classification:
A61B 18/18
US Classification:
606 32, 606 27, 606 33, 606 41
Abstract:
The present invention comprises methods and systems for treating a cardiac arrhythmia in a mammal by administering gated or pulsed radiofrequency current or other ablative energy to the mammal during one or more time periods of increased coronary blood flow. Preferred embodiments of the invention comprise, without limitation, the gated or pulsed administration of radiofrequency current in association with the formation of the dicrotic notch in the arterial blood pressure curve of the mammal. In accordance with the invention, the thermal effects of ablative energy application on the coronary artery are avoided or mitigated due to rapid coronary blood flow resulting in heat loss and minimization of damage to blood vessels.
Defibrillation Shock Strength Determination Technology
US Patent:
7257441, Aug 14, 2007
Filed:
Nov 12, 2003
Appl. No.:
10/706793
Inventors:
Charles D. Swerdlow - Los Angeles CA, US
Kalyanam Shivkumar - Los Angeles CA, US
Kalyanam Shivkumar - Los Angeles CA, US
International Classification:
A61N 1/39
US Classification:
607 8
Abstract:
A method for determining a cardiac shock strength, for example the programmed first-therapeutic shock strength of an implantable cardioverter defibrillator (ICD), including the steps of sensing a change in a T-wave of an electrogram with respect to time such as the maximum of the first derivative of a T-wave of an electrogram; delivering a test shock by (i) delivering a test shock at a test-shock strength and at a test-shock time relating to the maximum of the first derivative of the T-wave with respect to time; and (ii) sensing for cardiac fibrillation. If fibrillation is not sensed, test-shock delivery is repeated at the same test-shock strength and at specific, different test-shock times relating to the maximum of the first derivative of the T-wave. If fibrillation is still not sensed, the shock strength is decreased and test shocks are repeated at the same specific test shock times relative to the maximum of the first derivative of the T-wave. And if fibrillation is sensed, the programmed therapeutic shock strength of the ICD is set as a function of the incrementally greater test-shock strength.
Method To Protect The Esophagus And Other Mediastinal Structures During Cardiac And Thoracic Interventions
US Patent:
2009032, Dec 31, 2009
Filed:
May 28, 2009
Appl. No.:
12/474151
Inventors:
Kalyanam Shivkumar - Los Angeles CA, US
International Classification:
A61M 25/10, A61B 18/14
US Classification:
604506, 60410301, 604104, 606 41
Abstract:
Devices and methods are disclosed for preventing injury to a target tissue in proximity to the heart. The methods may include the use a device to externally manipulate the heart to move a portion of the heart away from the target tissue. The methods may also include applying therapy to the heart with the device.
Endovascular Catheter Air Block
US Patent:
8419685, Apr 16, 2013
Filed:
Nov 3, 2006
Appl. No.:
12/162474
Inventors:
Kalyanam Shivkumar - Los Angeles CA, US
David A. Cesario - Los Angeles CA, US
David A. Cesario - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61M 1/00, A61M 5/178
US Classification:
604122, 604126, 60416703
Abstract:
This invention is an air block for industrial, medical, and non-medical uses. For example, the air block is connected to the proximal end of a vascular access catheter. The air block is either removably connected to the proximal end of the catheter or it is integral to the proximal end of the catheter. The air block permits introduction of other catheters or instrumentation through its central lumen and on into a lumen of the catheter while minimizing fluid loss or gain into the catheter. The air block further prevents air from entering the catheter and provides for removal of the air or other gas from the central lumen before it can enter the catheter where it could cause harm to the patient. The air block can be attached to various standard proximal catheter terminations including Luer fittings and hemostasis valve outer barrels.